购物车
全部删除
您的购物车当前为空
hCAII-IN-9 是一种强效的碳酸酐酶抑制剂,对hCA II、hCA IX 和hCA XII 有抑制作用,IC50 分别为 1.18 μM 和 0.17 μM , and 2.99 μM 。hCAII-IN-9 没有血脑屏障透过性。


为众多的药物研发团队赋能,
让新药发现更简单!
hCAII-IN-9 是一种强效的碳酸酐酶抑制剂,对hCA II、hCA IX 和hCA XII 有抑制作用,IC50 分别为 1.18 μM 和 0.17 μM , and 2.99 μM 。hCAII-IN-9 没有血脑屏障透过性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 200 | 现货 | |
| 5 mg | ¥ 410 | 现货 | |
| 10 mg | ¥ 617 | 现货 | |
| 25 mg | ¥ 1,050 | 现货 | |
| 50 mg | ¥ 1,610 | 现货 | |
| 100 mg | ¥ 2,310 | 现货 | |
| 200 mg | ¥ 3,370 | 现货 |
hCAII-IN-9 相关产品
| 产品描述 | hCAII-IN-9 is a potent carbonic anhydrase inhibitor that inhibits hCA II, hCA IX, and hCA XII with IC50s of 1.18 μM and 0.17 μM , and 2.99 μM , respectively. hCAII-IN-9 is not blood-brain barrier permeable. |
| 靶点活性 | CA IX (human):0.17 μM, CA XII (human):2.99 μM, CA II (human):1.18 μM |
| 体外活性 | HCAII-IN-9(100 μM;24-48小时)对BHK-21和HEK-293细胞的抑制作用,使其细胞存活率分别降至48%和72%。[1] |
| 分子量 | 417.89 |
| 分子式 | C15H16ClN3O5S2 |
| CAS No. | 2878477-18-8 |
| Smiles | S(N)(=O)(=O)C1=C(NC(=O)C2=CC(C)=CC(C)=C2)C=C(Cl)C(S(N)(=O)=O)=C1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (131.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容